AACR logo

More articles from Research Article

Real-World Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study
Hong Zheng, Yunong Gao, Hongyan Guo, Li Li, Qingshui Li, Heng Cui, An Lin, Lixin Sun, Yuanjing Hu, Shan Kang, Wei Duan, Lingya Pan, Shuzhen Wang, Yingjie Yang, Yunxia Li, Weimin Kong, Yang Xiang, Xiaofei Tian, Bin Ling, Chunfang Ha, Wenpei Bai

Molecular Cancer Therapeutics Jan 2021, molcanther.1064.2020; DOI: 10.1158/1535-7163.MCT-20-1064
B-CATENIN ATTENUATION INHIBITS TUMOR GROWTH AND PROMOTES DIFFERENTIATION IN A BRAFV600E-DRIVEN THYROID CANCER ANIMAL MODEL
Minjing Zou, Huda A BinEssa, Yousif H Al-Malki, Suhad Al-Yahya, Monther Al-Alwan, Ibrahim Al-Jammaz, Khalid S. A. Khabar, Falah Almohanna, Abdullah M Assiri, Brian F. Meyer, Ali S Alzahrani, Futwan A Al-Mohanna, Yufei Shi

Molecular Cancer Therapeutics Jan 2021, molcanther.0037.2021; DOI: 10.1158/1535-7163.MCT-21-0037
Anti-glypican-1 antibody-drug conjugate as potential therapy against tumor cells and tumor vasculature for glypican-1 positive cholangiocarcinoma
Keiichiro Yokota, Satoshi Serada, Shigehiro Tsujii, Keisuke Toya, Tsuyoshi Takahashi, Takashi Matsunaga, Minoru Fujimoto, Sunao Uemura, Tsutomu Namikawa, Ichiro Murakami, Shogo Kobayashi, Hidetoshi Eguchi, Yuichiro Doki, Kazuhiro Hanazaki, Tetsuji Naka

Molecular Cancer Therapeutics Jan 2021, molcanther.0015.2021; DOI: 10.1158/1535-7163.MCT-21-0015
Recombinant Newcastle disease virus immunotherapy drives oncolytic effects and durable systemic antitumor immunity
James Harper, Shannon Burke, Jon Travers, Nicola Rath, Andrew Leinster, Christel Navarro, Ruth Franks, Rebecca Leyland, Kathy Mulgrew, Kelly McGlinchey, Lee Brown, Simon J. Dovedi, Jens-Oliver Koopmann, Nicholas M. Durham, Xing Cheng, Hong Jin, Jim Eyles, Robert W Wilkinson, Danielle Carroll

Molecular Cancer Therapeutics Jan 2021, molcanther.0902.2020; DOI: 10.1158/1535-7163.MCT-20-0902
ONC212 is a novel mitocan acting synergistically with glycolysis inhibition in pancreatic cancer
Isacco Ferrarini, Anna Louie, Lanlan Zhou, Wafik S. El-Deiry

Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-20-0962-A.2020; DOI: 10.1158/1535-7163.MCT-20-0962
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma
Matthias A Karajannis, Audrey Mauguen, Ekrem Maloku, Qingwen Xu, Erin M Dunbar, Scott R Plotkin, Anna Yaffee, Shiyang Wang, J Thomas Roland, Chandranath Sen, Dimitris G. Placantonakis, John G. Golfinos, Jeffrey C Allen, Nicholas A Vitanza, Luis A. Chiriboga, Robert J Schneider, Jingjing Deng, Thomas A Neubert, Judith D Goldberg, David Zagzag, Filippo G. Giancotti, Jaishri O Blakeley

Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-21-0143-A.2021; DOI: 10.1158/1535-7163.MCT-21-0143
VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases
Thomas L Ekstrom, Nicholas M. Pathoulas, Amelia M. Huehls, Arun Kanakkanthara, Larry M. Karnitz

Molecular Cancer Therapeutics Jan 2021, molcanther.1099.2020; DOI: 10.1158/1535-7163.MCT-20-1099
Gene expression signature correlates with outcomes in metastatic renal cell carcinoma patients treated with everolimus alone or with a vascular disrupting agent
Eddy S Yang, Amin H Nassar, Elio Adib, Opeyemi A Jegede, Sarah Abou Alaiwi, Deborah L Della Manna, David A Braun, Mahsa Zarei, Heng Du, Sumanta K Pal, Gurudatta Naik, Guru P Sonpavde

Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-20-1091-A.2020; DOI: 10.1158/1535-7163.MCT-20-1091
International consensus on minimum preclinical testing requirements for the development of innovative therapies for children and adolescents with cancer
Gilles Vassal, Peter J Houghton, Stefan M Pfister, Malcolm A. Smith, Huib N Caron, Xiao-Nan Li, David J Shields, Olaf Witt, Jan J Molenaar, Sara Colombetti, Julia Schuler, Lou F Stancato

Molecular Cancer Therapeutics Jan 2021, molcanther.0394.2020; DOI: 10.1158/1535-7163.MCT-20-0394
TARGETING THE T-CELL LYMPHOMA EPIGENOME INDUCES CELL DEATH, CANCER TESTES ANTIGENS, IMMUNE MODULATORY SIGNALING PATHWAYS.
Luigi Scotto, Cristina Kinahan, Eugene Douglass, Changchun Deng, Maryam Safari, Beatrice Casadei, Enrica Marchi, Jennifer K Lue, Francesca Montanari, Lorenzo Falchi, Changhong Qiao, Nandakumar Renu, Susan E. Bates, Andrea Califano, Owen A O'Connor

Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-20-0377-A.2020; DOI: 10.1158/1535-7163.MCT-20-0377

Main menu

User menu

Search

More articles from Research Article

Pages

Articles

Info for

About MCT